Insomnia treatment options for women

Obstetrics and Gynecology Clinics of North America
Judith R Davidson

Abstract

This article describes the circumstances under which women may develop insomnia and the various treatment options, including hypnotic medication and nonpharmacologic approaches. The efficacy and safety of these treatments are reviewed. The choice of treatment depends on the nature of the insomnia, the stage of a woman's life, the presence of medical or mental health conditions, the availability of treatments, and personal preference. For immediate, short-term relief of acute insomnia, hypnotic medication, especially the nonbenzodiazepines (zolpidem, zopiclone, eszopiclone) are options. For chronic insomnia, insomnia-specific cognitive and behavioral therapies are generally the interventions of choice.

References

Jan 1, 1992·Journal of Clinical Psychology·M Engle-FriedmanC Tsao
May 1, 1983·Journal of Clinical Pharmacology·K RickelsR Weinstock
Jan 1, 1994·Journal of Biological Rhythms·J Aschoff
Aug 1, 1994·The American Journal of Psychiatry·C M MorinS M Schwartz
Feb 1, 1997·Journal of Affective Disorders·M L PerlisD J Kupfer
Oct 27, 1997·The American Journal of Psychiatry·G E Simon, M VonKorff
Jul 1, 1997·General Hospital Psychiatry·M M WeissmanW C Dement
Jan 28, 1999·The Journal of Clinical Psychiatry·B A Dashevsky, M Kramer
Mar 23, 1999·JAMA : the Journal of the American Medical Association·C M MorinD Brink
Jan 5, 2000·The American Journal of Psychiatry·R E RobertsW J Strawbridge
Mar 25, 2000·Journal of Sleep Research·D LegerM Paillard
Mar 25, 2000·Journal of Sleep Research·C H Bastien, C M Morin
Apr 4, 2000·Journal of Women's Health & Gender-based Medicine·J L Shaver, S N Zenk
Mar 10, 2001·Annals of Internal Medicine·J R SantiagoT V Santiago
Apr 25, 2001·Journal of General Internal Medicine·A J BarskyJ F Borus
Jan 5, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Mohammad Masud IqbalThad Ryals
Jun 12, 2002·Endocrinology and Metabolism Clinics of North America·Alexandros N Vgontzas, George P Chrousos
Sep 28, 2002·Journal of Clinical Psychopharmacology·Gary S RichardsonThomas Roth
Jan 18, 2003·Sleep Medicine Reviews·Maurice M Ohayon
Jan 18, 2003·Sleep Medicine Reviews·Brant W. Riedel, Kenneth L. Lichstein
Feb 13, 2003·Journal of Community Health Nursing·Julie E Johnson
Feb 6, 2004·Journal of Consulting and Clinical Psychology·Lars StrömGerhard Andersson
Jun 10, 2004·Biological Research for Nursing·Rita E CheekMartha J Lentz
Aug 11, 2004·Journal of Consulting and Clinical Psychology·Célyne H BastienSébastien Bouchard
Dec 17, 2004·Behavioral Sleep Medicine·Jacqueline D KlossKelly Gilrain
Dec 17, 2004·Behavioral Sleep Medicine·Célyne H BastienCharles M Morin
Jan 15, 2005·Sleep Medicine Reviews·Frank A J L Scheer, Charles A Czeisler
Jan 22, 2005·Journal of Advanced Nursing·Hui-Ling Lai, Marion Good
Mar 5, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Ruth M Benca
Apr 9, 2005·The Journal of Clinical Psychiatry·Wallace B Mendelson
Jun 29, 2005·Journal of Psychopharmacology·David Wheatley
Aug 2, 2005·Lancet·Martha HickeyDavid W Sturdee
Aug 4, 2005·Journal of Biological Rhythms·Victoria L Revell, Charmane I Eastman
Sep 1, 2005·The Annals of Pharmacotherapy·Sarah T MeltonCynthia K Kirkwood
Oct 1, 2005·Archives of Women's Mental Health·C N Soares
Nov 15, 2005·BMJ : British Medical Journal·Jennifer GlassUsoa E Busto
Feb 2, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Michael R IrwinPerry M Nicassio
Dec 13, 2006·Clinical Therapeutics·Nancy L Borja, Karen L Daniel

❮ Previous
Next ❯

Citations

Aug 27, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Li-Wei ChienChi Feng Liu
Nov 2, 2011·Sleep·Michele L OkunLaura M Glynn
May 1, 2011·The Japanese Psychological Research·Michele L Okun
Jul 22, 2018·Journal of Behavioral Medicine·Michele L OkunMary Coussons-Read
Dec 12, 2020·Frontiers in Psychology·Christian FranceschiniGianluca Castelnuovo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.